Home > Financial Ratios > ORCHID PHARMA

ORCHID PHARMA
Price to Cash Earnings (PCE)

    Back to All Ratios
ORCHID PHARMA is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for ORCHID PHARMA
Please provide your vote to see the results

ORCHID PHARMA Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
   PCE(x) 14.2638.52736.19-0.24

What is the latest Price to Cash Earnings (PCE) ratio of ORCHID PHARMA ?

The latest Price to Cash Earnings (PCE) ratio of ORCHID PHARMA is 14.26 based on Mar2023 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar202314.26
Mar202238.52
Mar2021736.19
Mar2020-
Mar20190.24

How is Price to Cash Earnings (PCE) of ORCHID PHARMA Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2023 14.26
-62.98
Mar2022 38.52
-94.77
Mar2021 736.19
0
Mar2020 0
-100.00
Mar2019 0.24 -

Other Financial Ratios of ORCHID PHARMA


Compare Price to Cash Earnings (PCE) ratio of peers of ORCHID PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ORCHID PHARMA ₹5,508.3 Cr 2.6% 1.9% 175% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹365,167.0 Cr 2.6% -4.7% 54.7% Stock Analytics
CIPLA ₹113,645.0 Cr 4.4% -4.4% 54.7% Stock Analytics
DIVIS LABORATORIES ₹105,890.0 Cr 5.8% 17.7% 24.8% Stock Analytics
DR REDDYS LABORATORIES ₹104,987.0 Cr 5.7% 2.7% 29.3% Stock Analytics
ZYDUS LIFESCIENCES ₹96,950.6 Cr 0.4% -5.4% 82.7% Stock Analytics


ORCHID PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ORCHID PHARMA

2.6%

1.9%

175%

SENSEX

1.4%

2.5%

24.3%


You may also like the below Video Courses